Classical Ayurvedic therapy for benign prostatic enlargement in a geriatric patient: A case report
Keywords:
Benign prostatic hyperplasia, Prostomegaly, Vata-Kaphaja Mutraghata, Ayurvedic management, Chandraprabha Vati, Mutravirechana, achievement motivation, Agnimandya, SrotoshodhanaAbstract
Background: Benign prostatic hyperplasia (BPH), or prostomegaly, is a common urological condition in elderly men, characterized by urinary frequency, urgency, weak stream, and incomplete voiding. In Ayurveda, it can be correlated with Vata-Kaphaja Mutraghata associated with Agnimandya and Srotorodha. The Objective of the study is to evaluate the efficacy of a classical Ayurvedic regimen in managing BPH, targeting both symptomatic relief and underlying metabolic derangements. Case Presentation: A 68-year-old male presented with increased urinary frequency and urgency for 15–20 days, dry belching after exercise, right-sided headache, and chronic shoulder pain. Past history included hypertension for 10 years and nasal polypectomy. Ultrasonography revealed an enlarged prostate (61 cc), significant post-void residual urine, and bladder wall thickening. Ayurvedic assessment indicated Vata-Kaphaja Prakriti, Mandagni, and Kapha-Meda Dushti. Intervention: The patient was treated with a multidrug Ayurvedic regimen comprising Chandraprabha Vati, Haritakyadi Yoga, Gokshuradi Guggulu, Prameha Gajakesari, and other classical formulations, combined with dietary modifications and Nasya therapy. Medicines were administered with specific timing and anupana, with adjustments during follow-up based on clinical response. Outcome: Over three months, the patient experienced marked reduction in urinary frequency, urgency, suprapubic fullness, and associated systemic symptoms.
Downloads
References
review. Curr Urol Rep. 2024;25(1):1-8. doi: 10.1007/s11934-024-01234-5.
Shrivastava A. Various treatment options for benign prostatic hyperplasia. J Urol. 2012;188(4):1236-1242. doi: 10.1016/j.juro.2012.06.08.
Mantica G. Non-surgical management of BPH: An updated review. World J Urol. 2024;42(5):1123-1132. doi: 10.1007/s00345-024-03567-8.
Bhalodia SG, Bhuyan C, Gupta SK, Dudhamal TS. Gokshuradi Vati and Dhanyaka-Gokshura Ghrita Matra Basti in the management of benign prostatic hyperplasia. Ayu. 2012;33(4):547-551. doi: 10.4103/0974-8520.110532.
O'Quin C. Pharmacological approaches in managing symptomatic benign prostatic hyperplasia. Curr Urol Rep. 2023;24(1):45-52. doi: 10.1007/s11934-023-01234-5.
Sengupta G, et al. Comparison of Murraya koenigii- and Tribulus terrestris-based formulation versus tamsulosin in the treatment of benign prostatic hyperplasia. J Urol. 2011;186(3):1067-1072. doi: 10.1016/j.juro.2011.04.084.
Helman TA, et al. Advances in outpatient therapies and treatment of benign prostatic hyperplasia. Urology. 2024;129:1-8. doi: 10.1016/j.urology.2024.01.001.
Vasava YR, et al. Effect of Mahayavanala Roma Kshara and Dhanyaka-Gokshura Ghrita Matra Basti in the management of benign prostatic hyperplasia. Ayu. 2010;31(3):243-248. doi: 10.4103/0974-8520.77168.
Singh D, et al. Benign prostatic hyperplasia and sexual dysfunction: Review of the impact of new medical and surgical therapies on sexual health. Curr Urol Rep. 2025;26(1):49. doi: 10.1007/s11934-025-01279-z.
Santhosh K, et al. Management of a patient of hypertriglyceridemia with concurrent benign prostatic hyperplasia: An Ayurvedic approach. J Ayurveda Integr Med. 2023;14(2):123-128. doi: 10.1016/j.jaim.2023.01.005.
Plochocki AP, et al. Medical treatment of benign prostatic hyperplasia. Am Fam Physician. 2022;105(3):227-234. PMID: 35428429.
Dogra PN, et al. Comparative evaluation of Prostina and terazosin in the treatment of benign prostatic hyperplasia. J Indian Med Assoc. 2005;103(2):108-110. PMID: 16008322.
Sajan A, et al. Minimally invasive treatments for benign prostatic hyperplasia: A review. J Urol. 2022;208(4):789-795. doi: 10.1097/JU.0000000000002962.
Shirvan MK, et al. Pumpkin seed oil (Prostafit) versus prazosin in the treatment of benign prostatic hyperplasia: A randomized controlled trial. Phytomedicine. 2014;21(9):1156-1161. doi: 10.1016/j.phymed.2014.05.003.
Espinosa G, et al. Vitamin D and benign prostatic hyperplasia: A review. Urology. 2013;82(3):460-465. doi: 10.1016/j.urology.2013.03.045
Published
How to Cite
Issue
Section
Copyright (c) 2021 International journal of health sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.








